We are live on ! Find out more
GDRX icon

GoodRx Holdings

180 hedge funds and large institutions have $651M invested in GoodRx Holdings in 2022 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 46 increasing their positions, 55 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 34

3% more funds holding

Funds holding: 174180 (+6)

4% more call options, than puts

Call options by funds: $5.64M | Put options by funds: $5.44M

16% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 55

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

21.58% less ownership

Funds ownership: 186.97%165.4% (-22%)

29% less capital invested

Capital invested by funds: $916M → $651M (-$265M)

Holders
180
Holders Change
+6
Holders Change %
+3.45%
% of All Funds
3.1%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
40
Increased
46
Reduced
55
Closed
34
Calls
$5.64M
Puts
$5.44M
Net Calls
+$204K
Net Calls Change
+$274K
Name Holding Trade Value Shares
Change
Change in
Stake
LPL Financial
76
LPL Financial
California
$215K +$74.2K +11,769 +34%
Bank of New York Mellon
77
Bank of New York Mellon
New York
$213K -$15.6K -2,480 -5%
CW
78
CreativeOne Wealth
Kansas
$192K
KCPG
79
Kavar Capital Partners Group
Kansas
$192K
TRCT
80
Tower Research Capital (TRC)
New York
$187K +$173K +27,445 +216%
Commonwealth Equity Services
81
Commonwealth Equity Services
Massachusetts
$177K +$162K +25,699 +208%
CCP
82
Carmel Capital Partners
California
$174K +$15K +2,372 +7%
IA
83
IFP Advisors
Florida
$172K
BC
84
Bridgefront Capital
Texas
$170K +$230K +36,487 New
IA
85
Inspire Advisors
Idaho
$156K +$210K +33,318 New
JP Morgan Chase
86
JP Morgan Chase
New York
$154K +$38.2K +6,055 +23%
Janus Henderson Group
87
Janus Henderson Group
United Kingdom
$154K +$104K +16,470 +99%
GS
88
Gagnon Securities
New York
$153K +$328 +52 +0.2%
NC
89
NinePointTwo Capital
California
$150K
Citigroup
90
Citigroup
New York
$146K -$24.2K -3,841 -11%
Invesco
91
Invesco
Georgia
$145K -$448 -71 -0.2%
AG
92
Algert Global
California
$129K -$296K -46,935 -63%
T. Rowe Price Associates
93
T. Rowe Price Associates
Maryland
$118K +$6.3K +1,000 +4%
IFG
94
Independent Financial Group
California
$117K +$26.3K +4,175 +20%
BFM
95
Boothbay Fund Management
New York
$116K +$94.1K +14,935 +149%
Citadel Advisors
96
Citadel Advisors
Florida
$114K -$2.87M -454,995 -95%
Osaic Holdings
97
Osaic Holdings
Arizona
$111K -$19.7K -3,130 -12%
VRS
98
Virginia Retirement Systems
Virginia
$108K +$146K +23,200 New
UBS AM
99
UBS AM
Illinois
$105K +$36K +5,706 +34%
GAM
100
Gotham Asset Management
New York
$105K +$142K +22,471 New

GDRX Hedge Fund Activity: Q3 2022 in Review

180 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q3 2022, worth a combined $651M — down 29% from $916M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new GDRX positions and 34 closed out — a net gain of 6 holders — while 46 added to existing stakes and 55 trimmed.

The largest buyer was Jacobs Levy Equity Management, opening a new position worth an estimated $9.12M. The largest seller was Morgan Stanley, cutting an estimated $111M.

  • 180 institutional investors held GoodRx Holdings (GDRX) as of Q3 2022, up from 174 in Q2 2022.
  • Funds reported $651M of GoodRx Holdings stock for Q3 2022, down 29% quarter-over-quarter.
  • 40 funds opened new GoodRx Holdings positions in Q3 2022 and 34 closed out, a net change of +6 holders.
  • The largest GoodRx Holdings buyer in Q3 2022 was Jacobs Levy Equity Management, an estimated $9.12M added.
  • The largest GoodRx Holdings seller in Q3 2022 was Morgan Stanley, an estimated $111M sold.

Based on aggregated 13F filings for Q3 2022.